Kenvue /KVUE

$19.47

-0.56%
-
1D1W1MYTD1YMAX

About Kenvue

Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Ticker

KVUE

Sector

Consumer Non-Cyclicals

Trading on

NYSE

Industry

Personal & Household Prods.

CEO

Thibaut Mongon

Employees

22,000

Headquarters

Skillman, United States

Kenvue Metrics

BasicAdvanced
$37.49B
Market cap
22.29
P/E ratio
$0.88
EPS
-
Beta
$0.40
Dividend rate
4.09%
Dividend yield
$37.49B
$27.80
$17.82
16.35M
$0.40
1.12
0.782
68.567
73.91
46.03%
30.85
10.02%
6.03%
10.66%
7.27%
22.294
2.427
3.345
16.187
2.04%
4.09%
3.3%
-26.73%
2.2%

What the Analysts think about Kenvue

Analyst Ratings

Majority rating from 16 analysts.
Hold

Price Targets

Average projection from 12 analysts.
13.46% upside
High $25.04
Low $18.00
$19.47
Current price
$22.09
Average price target

Kenvue Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
8.91% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$3.67B
-6.36%
Net income
$327M
-25.34%
Profit margin
8.91%
-20.3%

Kenvue Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 10.66%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.37
$0.32
$0.31
$0.31
-
Expected
$0.32
$0.30
$0.31
$0.28
$0.26
Surprise
15.63%
5.96%
-1%
10.66%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Kenvue stock?

Kenvue (KVUE) has a market cap of $37.49B as of April 23, 2024.

What is the P/E ratio for Kenvue stock?

The price to earnings (P/E) ratio for Kenvue (KVUE) stock is 22.29 as of April 23, 2024.

Does Kenvue stock pay dividends?

Yes, the Kenvue (KVUE) stock pays dividends to shareholders. As of April 23, 2024, the dividend rate is $0.4 and the yield is 4.09%. Kenvue has a payout ratio of 46.03% on a trailing twelve-month basis.

When is the next Kenvue dividend payment date?

The next Kenvue (KVUE) dividend payment date is unconfirmed.

What is the beta indicator for Kenvue ?

Kenvue (KVUE) does not currently have a Beta indicator.

What is the Kenvue stock price target?

The target price for Kenvue (KVUE) stock is $22.09, which is 12.82% above the current price of $19.58. This is an average based on projections from 12 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Kenvue  stock

Buy or sell Kenvue stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing